TY - JOUR
T1 - Corrigendum to "Non-linear response and viscoelastic properties of lipid-coated microbubbles: DSPC versus DPPC" (vol 41, pg 1432-1445, 2015)
AU - van Rooij, Tom
AU - Luan, Ying
AU - Renaud, Guillaume
AU - van der Steen, Antonius F. W.
AU - Versluis, Michel
AU - De Jong, Nico
AU - Kooiman, Klazina
N1 - Publisher Copyright:
© 2021
PY - 2021/6
Y1 - 2021/6
N2 - The authors regret that there was a mistake in reporting the mol% of the microbubble coating composition used. For all experiments, the unit in mg/mL was used and the conversion mistake occurred only when converting to mol% to define the ratio between the coating formulation components. The correct molecular weight of PEG-40 stearate is 2046.54 g/mol (Shen et al. 2008; Kilic and Bolukcu 2018), not 328.53 g/mol. On page 1433, the sentence should read “The lipid coating was composed of 84.8 mol% DSPC (P6517, Sigma-Aldrich, Zwijndrecht, Netherlands) or DPPC (850355, Avanti Polar Lipids, Alabaster, AL, USA); 8.2 mol% polyoxyethylene-40-stearate (PEG40 stearate, P3440, Sigma-Aldrich); 5.9 mol% 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)2000 (DSPE-PEG2000, 880125, Avanti Polar Lipids); and 1.1 mol% 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[biotinyl(polyethylene glycol)-2000] (DSPE-PEG2000-biotin) (880129, Avanti Polar Lipids).” This correction does not change the conclusions published in this work.The authors apologize for any inconvenience caused.
AB - The authors regret that there was a mistake in reporting the mol% of the microbubble coating composition used. For all experiments, the unit in mg/mL was used and the conversion mistake occurred only when converting to mol% to define the ratio between the coating formulation components. The correct molecular weight of PEG-40 stearate is 2046.54 g/mol (Shen et al. 2008; Kilic and Bolukcu 2018), not 328.53 g/mol. On page 1433, the sentence should read “The lipid coating was composed of 84.8 mol% DSPC (P6517, Sigma-Aldrich, Zwijndrecht, Netherlands) or DPPC (850355, Avanti Polar Lipids, Alabaster, AL, USA); 8.2 mol% polyoxyethylene-40-stearate (PEG40 stearate, P3440, Sigma-Aldrich); 5.9 mol% 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)2000 (DSPE-PEG2000, 880125, Avanti Polar Lipids); and 1.1 mol% 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[biotinyl(polyethylene glycol)-2000] (DSPE-PEG2000-biotin) (880129, Avanti Polar Lipids).” This correction does not change the conclusions published in this work.The authors apologize for any inconvenience caused.
UR - http://www.scopus.com/inward/record.url?scp=85102517862&partnerID=8YFLogxK
U2 - 10.1016/j.ultrasmedbio.2021.02.011
DO - 10.1016/j.ultrasmedbio.2021.02.011
M3 - Article
VL - 47
SP - 1640
EP - 1640
JO - Ultrasound in medicine and biology
JF - Ultrasound in medicine and biology
SN - 0301-5629
IS - 6
ER -